Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13

Larimar Therapeutics, Inc. (NASDAQ:LRMR) is one of the 10 Small–Cap Stocks Insiders Are Buying Recently. On March 20, 2026, ...

Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed?

Larimar Therapeutics recently completed an upsized US$100,000,000 follow-on equity offering at US$5.00 per share, shortly ...
Seeking Alpha

Larimar Therapeutics Reports Third Quarter 2025 Financial Results

BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported ...
The Globe and Mail

Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
The Globe and Mail

Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering

BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...